Global Pharmacogenomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026

  • ID:PD015450
  • April 2020
  • Value Market Research
                          

The report on the Global Pharmacogenomics Market gives an estimation of the development of the market based on historical studies and also provides forecasts on the basis of comprehensive research. The report gives a complete market analysis for the forecasted period from 2020 to 2026. The market is portioned into various segments with an in-depth outlook of the competitive outlook and a listing of the profiled key players. The market size in terms of revenue (USD MN) is calculated and provided for the study period along with the dynamics of the market such as the drivers and the restraints.
 

Drivers

  • Growing demand for personalized drugs
  • Growing numbers of diseases
 
Restraints
  • High cost of R&D
 
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Till: 2026
 
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
 
The report classifies the market into different segments based on method, therapeutic application and application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
 
The report also covers the complete competitive landscape of the global Pharmacogenomics market with company profiles of key players such as:
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.

A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
 
SEGMENTATIONS IN THE REPORT:
By Method:
  • Haplotype Analysis
  • Multivariate Techniques
 
By Therapeutic Application:
  • Cancer
  • Oncology
  • Cardiovascular
 
By Applications:
  • Drug Safety
  • Tailor Treatments
  • Drug Discovery
 
By Geography:
  • North America (NA)
  • Europe (EU)
  • Asia Pacific (APAC)
  • Rest of the World (RoW)
 
The Global Pharmacogenomics Market has been exhibited in detail in the following chapters -
Chapter 1 Pharmacogenomics Market Preface 
Chapter 2 Executive Summary
Chapter 3 Pharmacogenomics Industry Analysis
Chapter 4 Pharmacogenomics Market Value Chain Analysis
Chapter 5 Pharmacogenomics Market Analysis By Method
Chapter 6 Pharmacogenomics Market Analysis By Therapeutic Application
Chapter 7 Pharmacogenomics Market Analysis By Applications
Chapter 8 Pharmacogenomics Market Analysis By Geography
Chapter 9 Competitive Landscape Of Pharmacogenomics Companies
Chapter 10 Company Profiles Of Pharmacogenomics Industry

METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

  • DecisionDatabases.com also provides specific research reports as per Client requirement.
  • Based on the feasibility, data can be provided for custom segmentation
 
DELIVERABLE OPTIONS:
 
DecisionDatabases.com also provides Mini Report and Sections of Reports, in case Client does not want to buy the full report: 
  • Market Data Sheet with all Tables and Graphs
  • Mini Report
  • Analysis
    • Drivers
    • Restraints
    • SWOT Analysis
    • Patent Analysis
  • Application Analysis
  • Product Analysis
  • Geography Analysis
  • Company Analysis
  • Competitive Landscape
  • Location of Plants
  • Company Profiles

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Pharmacogenomics Market
       2.2. Global Pharmacogenomics Market Snapshot
 
3 . PHARMACOGENOMICS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Pharmacogenomics Market
       3.3. Market Restraints of Pharmacogenomics Market
       3.4. Opportunities of Pharmacogenomics Market
       3.5. Trends of Pharmacogenomics Market
       3.6. Porter’s Five Force Analysis of Pharmacogenomics Market
       3.7. Pharmacogenomics Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Method
           3.7.2 Market Attractive Analysis by Therapeutic Application
           3.7.3 Market Attractive Analysis by Applications
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Pharmacogenomics Value Chain Analysis
       4.2. Pharmacogenomics Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Pharmacogenomics Raw Material Manufactures List
           4.2.3. Price Trend of Pharmacogenomics Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL PHARMACOGENOMICS MARKET ANALYSIS BY METHOD
       5.1 Overview by Method
       5.2 Global Pharmacogenomics Market Analysis by Method
       5.3 Market Analysis of Haplotype Analysis by Regions
       5.4 Market Analysis of Multivariate Techniques by Regions
 
6 . GLOBAL PHARMACOGENOMICS MARKET ANALYSIS BY THERAPEUTIC APPLICATION
       6.1 Overview by Therapeutic Application
       6.2 Global Pharmacogenomics Market Analysis by Therapeutic Application
       6.3 Market Analysis of Cancer by Regions
       6.4 Market Analysis of Oncology by Regions
       6.5 Market Analysis of Cardiovascular by Regions
 
7 . GLOBAL PHARMACOGENOMICS MARKET ANALYSIS BY APPLICATIONS
       7.1 Overview by Applications
       7.2 Global Pharmacogenomics Market Analysis by Applications
       7.3 Market Analysis of Drug Safety by Regions
       7.4 Market Analysis of Tailor Treatments by Regions
       7.5 Market Analysis of Drug Discovery by Regions
 
8 . GLOBAL PHARMACOGENOMICS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview
           8.3.2. North America Pharmacogenomics Market Estimate by Country
           8.3.3. United State
           8.3.4. Rest of North America
       8.4. Europe
           8.4.1. Overview
           8.4.2. Europe Pharmacogenomics Market Estimate by Market Segment
           8.4.3. Europe Pharmacogenomics Market Estimate by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7 Rest of Europe
       8.5. Asia Pacific
           8.5.1. Overview
           8.5.2. Asia Pacific Pharmacogenomics Market Estimate by Market Segment
           8.5.3. Asia Pacific Pharmacogenomics Market Estimate by Country
           8.5.4. China
           8.5.5. Japan
           8.5.6. India
           8.5.7. Rest of Asia Pacific
       8.6. Latin America
           8.6.1. Overview
           8.6.2. Latin America Pharmacogenomics Market Estimate by Market Segment
           8.6.3. Latin America Pharmacogenomics Market Estimate by Country
           8.6.4. Brazil
           8.6.5. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview
           8.7.2. Middle East & Africa Pharmacogenomics Market Estimate by Market Segment
           8.7.3. Middle East & Africa Pharmacogenomics Market Estimate by Country
           8.7.4. Middle East
           8.7.5. Africa
 
9 . COMPETITIVE LANDSCAPE OF THE PHARMACOGENOMICS COMPANIES
       9.1. Pharmacogenomics Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF PHARMACOGENOMICS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Abbott Laboratories, Inc.
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Affymetrix, Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. AstraZeneca plc
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. Bayer AG
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. Bristol-Myers Squibb Company
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. F. Hoffmann-La Roche Ltd.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. GE Healthcare
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. GlaxoSmithKline plc
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Johnson & Johnson
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
       10.12. Merck & Co., Inc.
           10.12.1. Company Overview
           10.12.2. Financials
           10.12.3. Products
           10.12.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES

  •  Global Pharmacogenomics Market Snapshot
  •  Drivers of The Global Pharmacogenomics Market Impact Analysis
  •  Restraints of The Global Pharmacogenomics Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Global Pharmacogenomics Market Analysis by Method (USD MN)
  •  Global Pharmacogenomics Market Analysis in Haplotype Analysis by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Multivariate Techniques by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis by Therapeutic Application (USD MN)
  •  Global Pharmacogenomics Market Analysis in Cancer by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Oncology by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Cardiovascular by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis by Applications (USD MN)
  •  Global Pharmacogenomics Market Analysis in Drug Safety by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Tailor Treatments by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Drug Discovery by Geography (USD MN)
  •  Global Pharmacogenomics Market by Geography (USD MN)
  •  North America Pharmacogenomics Market Analysis by Method (USD MN)
  •  North America Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  North America Pharmacogenomics Market Estimate by Applications (USD MN)
  •  North America Pharmacogenomics Market Estimate by Country (USD MN)
  •  United State Pharmacogenomics Market Analysis by Method (USD MN)
  •  United State Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  United State Pharmacogenomics Market Analysis by Applications (USD MN)
  •  Rest of North America Pharmacogenomics Market Analysis by Method (USD MN)
  •  Rest of North America Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Rest of North America Pharmacogenomics Market Estimate by Applications(USD MN)
  •  Europe Pharmacogenomics Market Analysis by Method (USD MN)
  •  Europe Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Europe Pharmacogenomics Market Estimate by Applications (USD MN)
  •  United Kingdom Pharmacogenomics Market Analysis by Method (USD MN)
  •  United Kingdom Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  United Kingdom Pharmacogenomics Market Estimate by Applications (USD MN)
  •  France Pharmacogenomics Market Analysis by Method (USD MN)
  •  France Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  France Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Germany Pharmacogenomics Market Analysis by Method (USD MN)
  •  Germany Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Germany Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Rest of Europe Pharmacogenomics Market Analysis by Method (USD MN)
  •  Rest of Europe Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Rest of Europe Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Asia Pacific Pharmacogenomics Market Analysis by Method (USD MN)
  •  Asia Pacific Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Asia Pacific Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Asia Pacific Pharmacogenomics Market Estimate by Country (USD MN)
  •  China Pharmacogenomics Market Analysis by Method (USD MN)
  •  China Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  China Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Japan Pharmacogenomics Market Analysis by Method (USD MN)
  •  Japan Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Japan Pharmacogenomics Market Estimate by Applications (USD MN)
  •  India Pharmacogenomics Market Analysis by Method (USD MN)
  •  India Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  India Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Rest of Asia Pacific Pharmacogenomics Market Analysis by Method (USD MN)
  •  Rest of Asia Pacific Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Rest of Asia Pacific Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Latin America Pharmacogenomics Market Analysis by Method (USD MN)
  •  Latin America Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Latin America Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Latin America Pharmacogenomics Market Estimate by Country (USD MN)
  •  Brazil Pharmacogenomics Market Analysis by Method (USD MN)
  •  Brazil Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Brazil Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Rest of Latin America Pharmacogenomics Market Analysis by Method (USD MN)
  •  Rest of Latin America Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Rest of Latin America Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Middle East & Africa Pharmacogenomics Market Analysis by Method (USD MN)
  •  Middle East & Africa Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Middle East & Africa Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Middle East & Africa Pharmacogenomics Market Estimate by Country (USD MN)
  •  Middle East Pharmacogenomics Market Analysis by Method (USD MN)
  •  Middle East Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Middle East Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Africa Pharmacogenomics Market Analysis by Method (USD MN)
  •  Africa Pharmacogenomics Market Estimate by Therapeutic Application (USD MN)
  •  Africa Pharmacogenomics Market Estimate by Applications (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
 
  •  Research Scope of Pharmacogenomics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Pharmacogenomics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Method
  •  Market Attractiveness Analysis by Therapeutic Application
  •  Market Attractiveness Analysis by Applications
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Pharmacogenomics Market Analysis by Method (USD MN)
  •  Global Pharmacogenomics Market Analysis in Haplotype Analysis by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Multivariate Techniques by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis by Therapeutic Application (USD MN)
  •  Global Pharmacogenomics Market Analysis in Cancer by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Oncology by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Cardiovascular by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis by Applications (USD MN)
  •  Global Pharmacogenomics Market Analysis in Drug Safety by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Tailor Treatments by Geography (USD MN)
  •  Global Pharmacogenomics Market Analysis in Drug Discovery by Geography (USD MN)
  •  Latin America Pharmacogenomics Market by Revenue
  •  Middle East & Africa Pharmacogenomics Market by Revenue
  •  Recent Development in Pharmacogenomics Industry
  •  Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Related Categories
Biotechnology
Related Reports
Global Biosimilars-on-Biologics Industry 2016 Market Research Report

The Global Biosimilars-on-Biologics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the  read more..


Global Real Time Location Systems in Healthcare Market Research Report

The report on the Global Real Time Location Systems In Healthcare Market gives an estimation of the development of the market based on historical studies  read more..


Global Healthcare Biometrics Market Research Report

The report on the Global Healthcare Biometrics Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Bio-Implants Market Research Report

The report on the Global Bio-Implants Market gives an estimation of the development of the market based on historical studies and also provides forecasts  read more..


Global 3D Printing In Medical Applications Market Research Report

The report on the Global 3D Printing In Medical Applications Market gives an estimation of the development of the market based on historical studies and  read more..


Global Orthobiologics Market Insights, Forecast to 2025

Orthobiologics Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global 3D Cell Culture Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global 3D Cell Culture Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Genome Engineering Market Research Report

The report on the Global Genome Engineering Market gives an estimation of the development of the market based on historical studies and also provides  read more..


Global Digital PCR (dPCR) Market Insights, Forecast to 2025

Digital PCR (dPCR) Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Bio-MEMS Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027

The report on the Global Bio-MEMS Devices Market gives an estimation of the development of the market based on historical studies and also provides  read more..